Project Management in the Pharmaceutical Industry: From Plan to Practice
Project Management in the Pharmaceutical Industry: Objectives and Results
Sticking to a schedule is important in Project Management in the Pharmaceutical Industry, but completing the planned activities does not guarantee the expected outcome. Costs, demand, and the availability of resources may change during implementation and alter the rationale for the investment.
Developing drugs, expanding facilities, and implementing regulatory compliance measures involve technical, operational, and financial decisions. Therefore, monitoring must take into account both the deliverables and the conditions necessary for them to produce the expected benefits.
How can we maintain this connection in practice? The process involves defining success criteria, planning for dependencies, and determining who should make decisions when the situation calls for adjustments.
A project starts with the result it needs to achieve
Before organizing activities, the company needs to clarify what it hopes to achieve. Entering a market, developing a product, or meeting a regulatory requirement each calls for its own specific success criteria.
This definition guides the business case: the justification that outlines the project's expected benefits, costs, risks, and assumptions.
In an interview with FIC Company, Pedro Malatesta, a project manager with more than ten years of experience in the pharmaceutical industry and at the Butantan Foundation, notes:
“More than just delivering the project on time, the project must produce the results outlined in the business case.”
Imagine that a company expands its factory to produce more medications. The construction is completed on schedule, but the equipment isn’t working yet, and the staff hasn’t received training. In this case, the building is ready, but production hasn’t increased. The project only achieves the expected result when the factory is able to produce the planned quantity at the required quality.
Cross-departmental collaboration and team availability
Research and development, quality, regulatory affairs, production, finance, marketing, and the supply chain are all involved in interconnected decisions. A need identified too late may require rework and result in changes to resources or deadlines.
Therefore, planning must involve those who will carry out the activities and those who will be affected by the deliverables. According to Pedro Malatesta, failure to identify these stakeholders can lead to changes in scope that compromise the planning process.
Furthermore, participating in a project does not mean full-time dedication. Professionals also balance their operational responsibilities.
The plan must specify who is responsible, what is required, and the agreed-upon availability. When there is a conflict of priorities, leaders should assess the teams’ actual capacity before committing to new deadlines.
Effective communication must lead to referrals
Information contributes to implementation when it reaches the right people in time to guide their actions. Dedicated communication channels and follow-up meetings facilitate this exchange, especially when professionals are dividing their attention among different activities.
However, sharing the problem is just the beginning. Each discussion should clarify:
- Which obstacle requires attention?.
- Who will assess its impacts?.
- What decision needs to be made?.
- Who is responsible for the referral?.
- When will there be another comeback?.
Documenting these points helps ensure that important information isn't limited to a single conversation. This way, the team can track the response and recognize when it needs to escalate the decision.
Project management in the pharmaceutical industry requires criteria for change
Even a well-thought-out plan requires adjustments. New information, technical difficulties, and external changes can alter the conditions under which the plan is carried out.
As Pedro Malatesta puts it:
“Even if you have a set formula for developing a new drug, every project will present a different challenge.”
This unique aspect requires assessing the risks and needs of each initiative, using past experience as a reference to guide decisions.
Governance defines how to evaluate these situations and who has the authority to make decisions. A change process must consider the reason for the change, its impacts on scope, timeline, cost, and resources, alternatives, and effects on the expected outcome.
According to Pedro Malatesta, the person responsible for the business case should be involved in decisions regarding significant changes. This involvement links the technical evaluation to the rationale for the investment.
A delay may be manageable in one project but could jeopardize an opportunity in another. Therefore, the analysis must take into account the significance of that deadline for the business.
A delay in supply may affect several deliveries
Consider the following scenario: A team plans a research phase, but the supplier indicates that it will take longer to make a necessary product available.
Updating the schedule doesn't solve the entire problem. The team needs to identify which activities depend on the material, how long they can wait, and which alternatives meet the project's requirements.
Purchasing, the requesting department, Quality, and other relevant technical departments must evaluate the options. An alternative available on the market should not be considered technically equivalent without this analysis.
Therefore, procurement and logistics must be factored into the planning process. Product, presentation, quantity, purpose, expiration date (when applicable), documentation, destination, and timeframe for need all help define the conditions for service.
Regulation and financial viability must go hand in hand with implementation
Regulatory requirements affect activities, documentation, resources, and the timeline. Their assessment should begin during the planning phase, with input from the relevant departments.
The regulatory strategy may also consider mechanisms such as regulatory trust, or reliance. In accordance with the applicable criteria, Anvisa may rely on assessments by other authorities, while retaining responsibility for the Brazilian decision. Learn more about the Use of Reliance in the Pharmaceutical Industry.
In international procurement, exchange rate fluctuations can affect costs and require a review of financial assumptions. When launching new drugs, however, the analysis must take into account the pricing rules applicable under the Drug Market Regulatory Agency (CMED).
Evaluating these factors together helps determine whether the project remains viable. Thus, decisions regarding implementation are aligned with the technical, regulatory, and economic conditions of the investment.
Metrics and technology should support decision-making
Timelines and budgets remain important, but they do not, on their own, provide a complete picture of the project’s status. Monitoring should also take into account risks, resource availability, dependencies, and expected benefits.
For each indicator, it is helpful to designate a person in charge and set a review frequency. That way, the team knows when a change requires analysis and who should conduct it.
Kanban boards, timelines, and short meetings can make priorities and obstacles visible. Artificial intelligence can also help consolidate information and prepare reports and timelines.
“A well-prepared, strategic project manager who knows how to use these tools and how to deliver value to the organization—I don’t think that person will be replaced.” — Pedro Malatesta.
Applying these tools requires verifying the data and evaluating the proposals generated. The value to management becomes apparent when the information helps identify risks, compare alternatives, and guide decisions.
From monitoring to the next decision
A project review can begin with objective questions: Is the expected outcome still feasible? Is there a dependency that threatens the next milestone? Is there a decision that hasn't been assigned to anyone? Does the team have the necessary capabilities?
These responses help turn monitoring into action. In project management within the pharmaceutical industry, reviewing the plan allows for adjustments to execution and a reassessment of the expected benefits in the business case.
More than just completing tasks, work must remain connected to the outcome that justified its creation.
Does your project involve purchasing, storing, or shipping products? Talk to the FIC Company team to align requirements and deadlines with the plan.
Share on:
Se inscrever
Login
0 Comments
Mais Votado
Mais Recente
Mais Antigo
Feedbacks Inline
Ver todos os comentários